Self-reported hepatitis B vaccination uptake and associated factors among adults in a tertiary hospital, Nasarawa State, Nigeria Authors: Stephen Olaide Aremu, Adamu Ishaku Akyala, Yakubu Boyi Ngwai, Abdillahi Abdi Barkhadle Published: 2026 ABSTRACT AbstractBackgroundHepatitis B virus (HBV) infection remains a major public health challenge in sub-Saharan Africa despite the availability of a safe and effective vaccine. In Nigeria, adult vaccination coverage and completion rates are not well characterized within hospital-based populations.MethodsA hospital-based cross-sectional study was conducted among 1,200 adults attending Federal Medical Centre (FMC) Keffi, Nasarawa State, Nigeria. Data on socio-demographics, HBV-related knowledge, attitudes, perceived barriers, vaccination uptake, and completion were collected using a structured questionnaire. Knowledge and attitude scores were categorized into poor, fair, and good levels. Associations between socio-demographic characteristics and vaccination uptake were examined using chi-square and Fisher’s exact tests, with statistical significance set at p < 0.05.ResultsThe mean age of respondents was predominantly 36–40 years (32.5%), with males constituting 72.3%. Most respondents had tertiary education (91.8%) and were civil servants (83.4%). Overall awareness of HBV was high (95.5%), with a mean knowledge score of 12.37 ± 1.42. Good knowledge was observed in 74.2% of respondents, while 57.2% demonstrated good attitudes toward HBV prevention. Vaccination uptake was high, with 93.5% reporting receipt of at least one vaccine dose. However, only 22.3% had completed the recommended three-dose schedule, while 48.2% and 23.1% had received one and two doses, respectively. Willingness to complete vaccination was reported by 81.6% of respondents. Perceived barriers included high vaccine cost (72.4%), inadequate access to health facilities (96.9%), fear of side effects (71.9%), and insufficient information (73.5%). No significant associations were found between socio-demographic variables and vaccination uptake (p > 0.05 for all).ConclusionDespite high HBV vaccination initiation and knowledge levels, substantial gaps in vaccine completion persist. Addressing financial, informational, and access-related barriers is essential to improve full vaccination coverage among Nigerian adults.Supplementary InformationThe online version contains supplementary material available at 10.1186/s40794-026-00311-5.Keywords: Hepatitis B, Vaccination uptake, Adults, Nigeria, Vaccine completion Introduction Hepatitis B virus (HBV) infection remains a leading cause of chronic liver disease globally, contributing substantially to liver cirrhosis, hepatocellular carcinoma, and premature mortality [1–5]. The World Health Organization (WHO) estimates that over 296 million people live with chronic HBV infection worldwide, with sub-Saharan Africa bearing a disproportionate share of this burden [6–7]. In Nigeria, HBV prevalence remains high, with adult seroprevalence estimates ranging from 8% to 12%, classifying the country as highly endemic [2]. This persistent burden underscores the urgent need for effective prevention strategies, particularly vaccination. Hepatitis B vaccination is one of the most cost-effective public health interventions available, providing more than 95% protection against infection and its long-term sequelae when the full three-dose schedule is completed [8–10]. While Nigeria integrated the hepatitis B vaccine into the National Programme on Immunization (NPI) for infants in 2004, with subsequent improvements in coverage, estimated at approximately 60–70% for the three-dose series in recent national reports, adult vaccination remains largely opportunistic, self-financed, and poorly regulated [1]. Consequently, adult vaccination coverage, completion rates, and determinants remain suboptimal and inadequately documented, particularly in hospital-based populations that may be at increased risk of exposure. Knowledge and attitudes toward HBV infection and vaccination play a critical role in influencing vaccination behavior. Previous studies in Nigeria and other African settings have reported varying levels of awareness, with knowledge gaps, misconceptions about transmission, fear of vaccine side effects, and low perceived susceptibility commonly identified as barriers to uptake [11–12]. Additionally, structural factors such as vaccine cost, limited availability, and inadequate health education by healthcare workers further impede optimal vaccination coverage [13–14]. Understanding how these factors interact within specific populations is essential for designing targeted interventions [1]. Hospital-based adult populations represent a unique group for HBV prevention efforts. Such populations may have increased exposure risk through medical procedures and more frequent interactions with healthcare providers, creating opportunities for health education and vaccination [15–17]. However, evidence suggests that high awareness does not always translate into complete vaccination, with many individuals initiating but failing to complete the recommended schedule [18–20]. Incomplete vaccination undermines individual and population-level protection, limiting progress toward HBV elimination targets. Despite the relevance of these issues, data on HBV vaccination uptake and completion among adults attending tertiary healthcare facilities in North-Central Nigeria remain scarce. Nasarawa State, located in a region with diverse socio-cultural and economic characteristics, provides an important context for examining Hep B vaccination behaviors among adults accessing tertiary care services. This study therefore aimed to assess Hepatitis B vaccination uptake, completion status, and associated knowledge, attitudes, and perceived barriers among adults attending Federal Medical Centre, Keffi. Specifically, the study examined levels of HBV-related knowledge and attitudes, identified perceived barriers to vaccination and completion, and explored associations between socio-demographic characteristics and vaccination uptake. Findings from this study are expected to inform hospital-based vaccination strategies, strengthen adult immunization policies, and contribute to Nigeria’s efforts toward achieving WHO hepatitis elimination goals. Methodology Study design and setting A hospital-based cross-sectional study was conducted at the Federal Medical Centre (FMC), Keffi, Nasarawa State, North-Central Nigeria (Fig. 1). FMC Keffi is a tertiary healthcare institution that serves as a major referral center for Nasarawa State and neighboring states, providing specialized medical services to a diverse adult population. The study was carried out among adult patients attending outpatient and inpatient services during the study period. Map of Nasarawa State showing Keffi local government area where Federal Medical Center, Keffi is located Study population The study population comprised adults aged 25–55 years who attended FMC Keffi during the period of data collection. Eligible participants included both male and female patients who were clinically stable and willing to participate in the study. Individuals who were critically ill, mentally incapacitated, or unable to provide informed consent were excluded. Younger adults (< 25 years) were excluded to focus on those likely completing education and entering the workforce, and older adults (> 55) were excluded to reduce potential recall bias regarding vaccination history. Sample size determination The sample size was determined using the single population proportion formula for cross-sectional studies. Assuming an expected Hepatitis B vaccination uptake of 50% due to limited prior data in similar hospital-based adult populations, a 95% confidence level (Z = 1.96), and a margin of error of 3%, a minimum sample size of 1,067 was calculated. To account for potential non-response and incomplete questionnaires, the sample size was increased by 12%, yielding 1,195, which was then rounded up to a final target sample size of 1,200 respondents. Sampling technique A systematic sampling technique was employed. Based on the average daily adult patient attendance at FMC Keffi and the desired sample size, a sampling interval (k) was calculated by dividing the estimated number of eligible patients by the required number of participants, yielding k = 3. Each day, the first participant was selected using simple random sampling, after which every 3rd eligible patient was recruited until the required sample size was achieved. Recruitment was proportionately allocated across major hospital departments to ensure representativeness. Data collection instrument Data were collected using a structured, interviewer-administered questionnaire developed following an extensive review of relevant literature. The questionnaire consisted of six sections: socio-demographic characteristics, knowledge of Hepatitis B virus and vaccination, attitudes toward Hepatitis B infection and vaccination, perceived barriers to vaccination, Hepatitis B vaccination uptake and completion status, and reasons for non-uptake or incomplete vaccination. The questionnaire was reviewed by public health and infectious disease experts for content validity and pretested among 5% of the calculated sample size at a different health facility. Necessary modifications were made to improve clarity and reliability. The internal consistency of the knowledge and attitude scales was assessed using Cronbach’s alpha, with values of 0.78 for the knowledge scale and 0.81 for the attitude scale, indicating good reliability and strengthening the credibility of the instrument. Measurement of variables Hepatitis B vaccination uptake was defined as self-reported receipt of at least one dose of the Hepatitis B vaccine. Full vaccination was defined as completion of the nationally recommended three-dose schedule at 0, 1, and 6 months. Knowledge of Hepatitis B infection and vaccination was assessed using 15 items, with each correct response scoring one point. The maximum obtainable score was 15. Knowledge levels were categorized as poor (≤ 7), fair (8–11), and good (12–15). Attitude toward Hepatitis B infection and vaccination was assessed using Likert-scale statements. Aggregate attitude scores were categorized into poor, fair, and good attitudes based on predefined cut-off points. Perceived barriers to vaccination were measured using five-point Likert-scale items, with higher mean scores indicating stronger perceived barriers. Data collection procedure Trained research assistants administered the questionnaires through face-to-face interviews after obtaining informed consent from participants. Interviews were conducted in English, with clarifications provided in local languages where necessary. Completed questionnaires were reviewed daily for completeness and consistency. Data analysis Data were entered and analyzed using the Statistical Package for Social Sciences (SPSS) version 26. Descriptive statistics, including frequencies, percentages, means, and standard deviations, were computed to summarize respondents’ socio-demographic characteristics, knowledge, attitudes, perceived barriers, and vaccination uptake. For inferential analysis, associations between independent variables (socio-demographic characteristics, knowledge, attitudes, and perceived barriers) and the dependent variable (Hepatitis B vaccination uptake) were assessed using the Chi-square (χ²) test of independence. Categorical variables with more than two categories (e.g., age group, educational level, marital status) were initially analyzed using Chi-square tests with full category structures (r × c tables) rather than restricting analyses to 2 × 2 comparisons. Where appropriate, categories were collapsed or recoded to ensure adequate cell counts and meaningful interpretation. For example: Educational level was grouped into low (none/primary), medium (secondary), and high (tertiary). Educational level was grouped into low (none/primary), medium (secondary), and high (tertiary). Marital status was recoded into currently married vs. not currently married where necessary. Marital status was recoded into currently married vs. not currently married where necessary. Age was categorized into meaningful groups based on distribution (e.g., ≤ 25, 26–35, ≥ 36 years). Age was categorized into meaningful groups based on distribution (e.g., ≤ 25, 26–35, ≥ 36 years). When expected cell counts in contingency tables were less than five, Fisher’s exact test was used to ensure the validity of the results. To further examine predictors of vaccination uptake and control for potential confounding variables, binary logistic regression analysis was performed. Variables that were significant at p < 0.20 in bivariate analysis were included in the multivariable model. Categorical variables included in the regression model were dummy coded, with one category selected as the reference group (e.g., tertiary education as reference for education level). Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were reported. All statistical tests were two-tailed, and statistical significance was set at p < 0.05. Ethical considerations Ethical approval for the study was obtained from the Health Research Ethics Committee of FMC Keffi (Ethical clearance number: FMC/KF/HREC/02881/25), received on 10th July 2025. Prior to data collection, written informed consent was obtained from all participants. The consent process included a clear explanation of the study’s purpose, procedures, potential risks and benefits, and was conducted in a language understandable to participants. Participation was entirely voluntary, and respondents were informed of their right to withdraw from the study at any time without any consequences. Interviews were conducted by trained research assistants who received guidance on ethical conduct, maintaining confidentiality, and techniques to minimize interviewer bias. All data were anonymized, securely stored, and accessible only to the study team to ensure confidentiality and integrity. No personal identifiers were collected, and data handling adhered to ethical standards for research involving human participants. Results Socio-demographic characteristics of respondents A total of 1,200 patients attending FMC Keffi were surveyed (Table 1). Most respondents were aged 36–40 years (32.5%), followed by those aged 31–35 years (23.8%) and 41–45 years (21.9%). The majority were male (72.3%). Educational attainment was predominantly tertiary level (91.8%), while civil servants constituted the largest occupational group (83.4%). Most respondents were married (94.0%), indicating a largely adult, educated, and socio-economically stable patient population attending FMC Keffi. Table 1Socio-demographic profile of patients attending FMC Keffi (n = 1,200)VariableCategoryFrequency (n)Percentage (%)Age group (years)25–30877.231–3528523.836–4039032.541–4526321.946–5013611.351–55393.3SexMale86772.3Female33327.8Educational levelNone373.1Primary90.8Secondary534.4Tertiary1,10191.8OccupationCivil servant1,00183.4Business1058.8Farmer100.8SME211.8Student30.3Housewife292.4Artisan60.5Tailor252.1Marital statusSingle161.3Married1,12894.0Divorced/Widowed564.7 Socio-demographic profile of patients attending FMC Keffi (n = 1,200) Knowledge of hepatitis B virus and vaccination Assessment of respondents’ knowledge regarding Hepatitis B infection and vaccination revealed generally high awareness levels (Table 2). Most respondents correctly identified blood transmission, sexual transmission, mother-to-child transmission as a major route of infection (96.5%), while only 3.5% reported not knowing any transmission route. Awareness of Hepatitis B virus was high, with 95.5% of respondents agreeing or strongly agreeing that they were aware of the virus. Regarding vaccination, 74.2% agreed or strongly agreed that the Hepatitis B vaccine is effective, and 63.8% believed the vaccine is safe and recommended for all age groups. Additionally, over half of the respondents (57.2%) acknowledged that lack of awareness negatively affects vaccination uptake. Overall, these findings indicate a relatively good level of knowledge about Hepatitis B infection and vaccination among patients attending FMC Keffi. Table 2Knowledge of hepatitis B infection and vaccination among respondents (n = 1,200)Knowledge IndicatorResponse CategoryFrequency (n)Percentage (%)Knowledge of transmission routesCorrect (Blood, Sexual, or Mother-to-child)1,15896.5Do not know423.5Awareness of Hepatitis B virusAgree/Strongly agree1,14695.5Undecided/Disagree/Strongly disagree544.5Belief that vaccine is effectiveAgree/Strongly agree89174.3Disagree/Undecided30925.7Belief that vaccine is safe and recommended for all agesYes76663.8No43436.2Perception that lack of awareness affects vaccinationYes68657.2Not sure/No51442.8 Knowledge of hepatitis B infection and vaccination among respondents (n = 1,200) Knowledge of Hepatitis B virus and vaccination was assessed using a composite score derived from 15 knowledge-related items, with a maximum obtainable score of 15 (Fig. 2). The mean knowledge score was 12.37 ± 1.42. Knowledge levels were categorized into three groups: poor knowledge (scores 7–7), fair knowledge (scores 8–11), and good knowledge (scores 12–15) (Appendix I). The assessment of respondents’ overall knowledge of Hepatitis B infection and vaccination showed that the majority had a good level of knowledge. Specifically, 74.2% of respondents demonstrated good knowledge, while 25.6% had moderate knowledge. Only a very small proportion of respondents (0.3%) exhibited poor knowledge (Table 3). This distribution indicates that most patients attending FMC Keffi possess adequate knowledge regarding Hepatitis B and its vaccination, although a notable minority still have only a fair level of understanding. Pie chart showing the knowledge Level of the Participants Table 3Respondents’ attitudes toward hepatitis B infection and vaccination (n = 1200)Attitude StatementResponseFrequencyPercent (%)Believe Hepatitis B is a serious health problem in NigeriaYes82368.6No37731.4Feel personally at risk of contracting Hepatitis BHighly at risk100483.7Moderately at risk1068.8Slightly at risk302.5Not at risk at all605.0Believe vaccination is necessary for protecting healthAgree90575.4Strongly agree20.2Disagree16713.9Strongly disagree12610.5Religious/cultural beliefs affect vaccination decisionAgree40834.0Strongly agree867.2Disagree69958.3Strongly disagree70.6Would encourage family/friends to vaccinateYes109891.5No1028.5 Respondents’ attitudes toward hepatitis B infection and vaccination (n = 1200) Attitudes toward hepatitis B infection and vaccination Table 3 presents the attitudes of 1,200 respondents toward Hepatitis B infection and vaccination. Most respondents (68.6%) believed that Hepatitis B is a serious health problem in Nigeria, while 31.4% did not consider it serious. Most respondents (83.7%) felt highly at risk of contracting Hepatitis B, 8.8% felt moderately at risk, 2.5% slightly at risk, and 5.0% not at risk at all. Regarding the necessity of vaccination for protecting health, 75.6% of respondents agreed, whereas 24.4% disagreed. About 41.2% of respondents indicated that religious or cultural beliefs influence their vaccination decision, while 58.8% reported that such beliefs do not affect their decision. Finally, an overwhelming majority (91.5%) stated that they would encourage family or friends to vaccinate, compared to 8.5% who would not. Out of 1,200 respondents, 57.2% demonstrated a good attitude toward Hepatitis B infection and vaccination, 39.8% had a fair attitude, and 3.0% exhibited a poor attitude (Fig. 3). Pie chart showing attitude Level of the Participants Perceived barriers to hepatitis B vaccination The perceived barriers to Hepatitis B vaccination among the 1,200 respondents revealed that most respondents (72.4%) agreed or strongly agreed that the vaccine is expensive or not affordable, while 27.7% disagreed or strongly disagreed (Table 4). Most respondents (96.9%) agreed or strongly agreed that inadequate access to health facilities limits vaccine uptake, with only 3.1% disagreeing. About 71.9% of respondents agreed or strongly agreed that fear of side effects prevents them from getting vaccinated, while 28.2% disagreed or strongly disagreed. A total of 73.5% agreed or strongly agreed that lack of adequate information discourages vaccination, whereas 26.5% disagreed or strongly disagreed. More than half (57.8%) agreed or strongly agreed that health workers do not provide enough education on Hepatitis B vaccination, while 42.2% disagreed or strongly disagreed (Table 6). Table 4Perceived barriers to hepatitis B vaccine uptake among respondents (n = 1200)Perceived BarrierResponseFrequencyPercent (%)Vaccine is expensive/not affordableStrongly agree16914.1Agree69958.3Disagree29624.7Strongly disagree363.0Inadequate access to health facilities limits uptakeStrongly agree77564.6Agree38832.3Disagree322.7Strongly disagree50.4Fear of side effects prevents vaccinationStrongly agree52944.1Agree33327.8Disagree22518.8Strongly disagree1139.4Lack of adequate information discourages vaccinationStrongly agree54845.7Agree33427.8Disagree20417.0Strongly disagree1149.5Health workers don’t provide enough educationStrongly agree17414.5Agree52043.3Disagree34228.5Strongly disagree16413.7 Perceived barriers to hepatitis B vaccine uptake among respondents (n = 1200) Table 6Hepatitis B vaccination uptake by socio-demographic characteristics of respondents (n = 1,200)VariableCategoryNot Vaccinated n (%)Vaccinated n (%)Total n (%)χ² (df)p-valueAge group (years)25–301 (1.1)86 (98.9)87 (100.0)5.183 (5)0.39431–3520 (7.0)265 (93.0)285 (100.0)36–4024 (6.2)366 (93.8)390 (100.0)41–4519 (7.2)244 (92.8)263 (100.0)46–5011 (8.1)125 (91.9)136 (100.0)51–553 (7.7)36 (92.3)39 (100.0)Total— 78 (6.5) 1,122 (93.5)1,200 (100.0)SexFemale16 (4.8)317 (95.2)333 (100.0)—0.152*Male62 (7.1)805 (92.9)867 (100.0)Total— 78 (6.5) 1,122 (93.5)1,200 (100.0)Educational levelNone1 (2.7)36 (97.3)37 (100.0)1.291 (3)0.731Primary1 (11.1)8 (88.9)9 (100.0)Secondary4 (7.5)49 (92.5)53 (100.0)Tertiary72 (6.5)1,029 (93.5)1,101 (100.0)Total— 78 (6.5) 1,122 (93.5)1,200 (100.0)OccupationBusiness9 (8.6)96 (91.4)105 (100.0)2.285 (7)0.942Farmer0 (0.0)10 (100.0)10 (100.0)Civil servant64 (6.4)937 (93.6)1,001 (100.0)SME1 (4.8)20 (95.2)21 (100.0)Student0 (0.0)3 (100.0)3 (100.0)Housewife2 (6.9)27 (93.1)29 (100.0)Artisan0 (0.0)6 (100.0)6 (100.0)Tailor2 (8.0)23 (92.0)25 (100.0)Total— 78 (6.5) 1,122 (93.5)1,200 (100.0)Marital statusSingle0 (0.0)16 (100.0)16 (100.0)1.274 (2)0.529Married75 (6.6)1,053 (93.4)1,128 (100.0)Divorced/Widowed3 (5.4)53 (94.6)56 (100.0)Total— 78 (6.5) 1,122 (93.5)1,200 (100.0)*Fisher’s Exact Test for 2 × 2 Hepatitis B vaccination uptake by socio-demographic characteristics of respondents (n = 1,200) *Fisher’s Exact Test for 2 × 2 Hepatitis B vaccination uptake and willingness Table 5 presents hepatitis B vaccination uptake, dosing patterns, and perceived facilitators among 1,200 respondents. The data show a high initiation rate, with 93.5% having received at least one dose; however, completion of the full three-dose schedule was low at 22.3%, indicating substantial early attrition. Among those who had not completed the series (n = 933), 76.3% were willing to complete vaccination, reflecting generally positive attitudes. Facilitators such as vaccine availability at FMC Keffi and increased public awareness were strongly endorsed, with over 96% of respondents agreeing. These findings highlight that while willingness is high, logistical barriers and limited awareness impede full vaccination completion. Table 5Hepatitis B vaccination uptake, willingness, and perceived facilitators among respondents (n = 1200)Vaccination IndicatorResponseFrequencyPercent (%)VaccinatedYes112293.5No786.5Received doseNone786.5One dose57848.2Two doses27723.1Three doses (full dose)26722.3Willing to complete full vaccination scheduleYes71276.3No22123.7Would willingly vaccinate if available at FMC KeffiYes115496.2No463.8Increasing public awareness will improve uptakeYes115396.1No473.9 Hepatitis B vaccination uptake, willingness, and perceived facilitators among respondents (n = 1200) Analysis of the association between socio-demographic characteristics and Hepatitis B vaccination uptake showed no statistically significant relationships across all variables examined (Table 6). Vaccination uptake was consistently high across all age groups, ranging from 91.9% to 98.9%, with no significant association observed between age group and vaccination status (χ² = 5.183, df = 5, p = 0.394). Similarly, vaccination coverage was slightly higher among females (95.2%) than males (92.9%); however, this difference was not statistically significant (Fisher’s Exact Test, p = 0.152). Educational level was also not significantly associated with vaccination uptake, with high coverage observed across all categories, including respondents with tertiary education (93.5%) (χ² = 1.291, df = 3, p = 0.731). With respect to occupation, vaccination uptake exceeded 90% in all occupational groups, and no statistically significant association was found between occupation and vaccination status (χ² = 2.285, df = 7, p = 0.942). Marital status likewise showed no significant relationship with Hepatitis B vaccination uptake, as high vaccination coverage was observed among single, married, and divorced/widowed respondents (χ² = 1.274, df = 2, p = 0.529). These findings indicate that Hepatitis B vaccination uptake among patients attending FMC Keffi was uniformly high and did not vary significantly across socio-demographic characteristics. Reasons for non-uptake or incomplete vaccination Analysis of the main reasons for non-vaccination revealed that most respondents (93.4%) had already received the Hepatitis B vaccine and therefore reported no reason for non-vaccination. Among the small proportion who were unvaccinated, the most frequently cited reasons were high vaccine cost (1.8%) and lack of funds or economic constraints (1.6%). Other reported reasons included lack of time (1.4%), unavailability of the vaccine (1.3%), fear of vaccine side effects (0.3%), and lack of trust in vaccine quality (0.2%). Overall, financial and access-related barriers were more prominent than concerns related to vaccine safety or trust among unvaccinated respondents. The assessment of perceived reasons for non-vaccination and incomplete Hepatitis B vaccination among respondents revealed several prominent barriers (Fig. 4). Lack of information on where to obtain the vaccine recorded a high mean score (3.99 ± 0.99), indicating strong agreement that this was a major barrier. Financial constraints were also notable, as inability to afford vaccine cost had a mean score of 2.80 ± 0.65. Incomplete vaccination was particularly pronounced, with “starting but not completing the vaccination schedule” recording the highest level of agreement (3.61 ± 0.55). Fear of side effects moderately influenced vaccination behavior (2.98 ± 1.03), while low perceived risk of Hepatitis B infection also contributed substantially to non-vaccination decisions (3.11 ± 0.99) (Table 7). These findings indicate that informational gaps, affordability, failure to complete vaccination schedules, fear of side effects, and low risk perception are key factors influencing Hepatitis B vaccination behavior among patients attending FMC Keffi. Main reasons for not receiving hepatitis B vaccination among respondents (n = 1,200) Table 7Perceived reasons for non-vaccination and incomplete hepatitis B vaccination among respondents (n = 78)Barrier StatementMeanSDStrongly Disagree n (%)Disagree n (%)Undecided n (%)Agree n (%)Strongly Agree n (%)Did not know where to get vaccine3.990.990 (0.0)3 (3.8)12 (15.4)21 (26.9)42 (53.8)Could not afford vaccine cost2.800.652 (2.6)15 (19.2)0 (0.0)45 (57.7)16 (20.5)Started but did not complete schedule3.610.551 (1.3)2 (2.6)0 (0.0)25 (32.1)50 (64.1)Fear of side effects prevented completion2.981.038 (10.3)12 (15.4)0 (0.0)24 (30.8)34 (43.6)Does not feel at risk of Hepatitis B3.110.996 (7.7)10 (12.8)0 (0.0)25 (32.1)37 (47.4)Note: Analysis restricted to respondents who were unvaccinated or did not complete the full vaccination schedule (at-risk group). Percentages are calculated based on this subgroup (n = 78), not the total sample Perceived reasons for non-vaccination and incomplete hepatitis B vaccination among respondents (n = 78) Note: Analysis restricted to respondents who were unvaccinated or did not complete the full vaccination schedule (at-risk group). Percentages are calculated based on this subgroup (n = 78), not the total sample Analysis of perceived barriers was restricted to respondents who were either unvaccinated or had not completed the full vaccination schedule (n = 78). Percentages were calculated using this subgroup to provide a more accurate representation of constraints to vaccine uptake. The most prominent barriers included lack of knowledge of where to obtain the vaccine (80.7% agreed/strongly agreed), inability to afford the vaccine (78.2%), and failure to complete the vaccination schedule once initiated (96.2%). Fear of side effects and low perceived risk of infection were also commonly reported. Discussion This study provides comprehensive evidence on Hepatitis B vaccination uptake, completion status, and associated knowledge, attitudes, and perceived barriers among adults attending a tertiary healthcare facility in North-Central Nigeria. The findings reveal a paradoxical pattern: although awareness, knowledge, and initiation of Hepatitis B vaccination were remarkably high, completion of the full three-dose schedule remained suboptimal, highlighting critical gaps in adult immunization delivery and continuity of care. The overall vaccination uptake of 93.5% observed in this study is substantially higher than rates reported in many Nigerian and sub-Saharan African studies, where adult vaccination coverage often ranges between 20% and 70% [12, 21–28], However, it must be noted that most of the studies have healthcare workers as the study population. This unusually high uptake may be attributable to the hospital-based nature of the study population, the predominance of educated respondents, and the large proportion of civil servants who may have better access to health information and services. High awareness of Hepatitis B (95.5%) and a strong belief in vaccine effectiveness (74.2%) further reinforce the likelihood of vaccine initiation in this population. These findings underscore the importance of healthcare contact as a critical entry point for adult vaccination. Despite this high initiation rate, only 22.3% of respondents completed the full three-dose vaccination schedule, indicating a substantial drop-off after the first dose. Nearly half (48.2%) had received only one dose, suggesting early attrition in the vaccination cascade. This aligns with previous studies showing that initiation does not always translate into completion for multi-dose vaccines [14–16]. Incomplete vaccination reduces optimal protection and undermines hepatitis elimination efforts. A contributing factor in sub-Saharan Africa may be the reliance on pediatric-dose hepatitis B vaccine formulations for adults due to limited availability of adult-specific options. These often require extended dosing schedules, making completion more difficult in resource-constrained settings. In contrast, shorter adult-dose regimens could improve adherence but are not widely accessible [29–33]. Strengthening procurement and access to appropriate adult formulations (just 2 vaccine doses) may help improve vaccination completion rates [34]. Knowledge levels were generally high, with nearly three-quarters of respondents demonstrating good knowledge of Hepatitis B infection and vaccination. However, the persistence of incomplete vaccination despite adequate knowledge suggests that information alone is insufficient to ensure full vaccine uptake. This observation aligns with behavioral health models which posit that structural and contextual barriers often outweigh cognitive factors in shaping health behaviors [35–39]. Indeed, perceived barriers such as high vaccine cost, inadequate access to vaccination services, fear of side effects, and insufficient guidance from healthcare workers were strongly endorsed by respondents [34–36]. Although a high proportion of respondents reported fear of side effects and limited information as barriers, most would encourage others to vaccinate, and slightly above four-fifth of the respondents were willing to complete vaccination. This apparent contradiction suggests that personal concerns do not necessarily prevent positive attitudes or advocacy. Social responsibility, professional norms, or recognition of vaccination benefits may drive encouragement. Financial constraints emerged as a prominent barrier, both in the perception data and among unvaccinated respondents. Although most participants were civil servants, the cost of adult Hepatitis B vaccination, typically borne out-of-pocket in Nigeria, remains a deterrent, particularly when multiple doses are required [37]. This finding reinforces calls for policy interventions that subsidize or integrate adult Hepatitis B vaccination into routine healthcare services, especially within tertiary hospitals where uptake potential is high. Fear of side effects and low perceived risk of infection also significantly influenced vaccination behavior, particularly completion. While most respondents felt highly susceptible to Hepatitis B, a notable proportion still reported low risk perception as a reason for non-vaccination or non-completion [38, 40]. This apparent contradiction may reflect optimism bias or diminishing perceived risk after receiving one or two doses. Strengthening risk communication and counseling at each vaccination encounter may therefore be critical to improving completion rates. Interestingly, no significant associations were observed between socio-demographic characteristics and vaccination uptake. This uniformity likely reflects the overwhelmingly high initiation rate across all subgroups and suggests that barriers to completion are more systemic than demographic in nature. Such findings further support the argument that improving vaccine delivery systems, rather than targeting specific demographic groups, may yield greater gains in adult Hepatitis B control [22–25, 41]. The strong willingness expressed by respondents to complete vaccination and the near-universal agreement that increased awareness would improve uptake indicate substantial unmet demand and opportunity for intervention. Hospital-based reminder systems, dose-tracking mechanisms, and healthcare worker–led follow-up could capitalize on this willingness and reduce attrition across doses. Strengths and limitations This study benefits from a large sample size, comprehensive assessment of behavioral and structural factors, and robust statistical analysis. However, the findings should be interpreted in light of certain limitations. Vaccination status was self-reported and may be subject to recall and social desirability bias. In addition, the hospital-based design limits the generalizability of the findings to the wider community, particularly populations with limited access to healthcare services. Importantly, the demographic profile of the respondents, characterized by a high proportion of civil servants, relatively high educational attainment, and a marked male predominance, may not be representative of the general population. This distribution likely reflects the sampling approach within a tertiary hospital setting, where even with randomization, certain groups are more likely to be captured. As such, this introduces potential selection bias and further restricts the external validity of the findings, particularly for rural or underserved populations. Finally, due to the cross-sectional nature of the study, causal relationships between variables cannot be established. Implications for policy and practice The findings highlight the need for a paradigm shift from focusing solely on vaccination initiation to ensuring completion of the full Hepatitis B vaccine schedule among adults. Integrating adult Hepatitis B vaccination into routine hospital services, reducing financial barriers, strengthening healthcare worker engagement, and implementing reminder and follow-up systems are critical strategies for closing existing gaps. Conclusion Hepatitis B vaccination initiation among adults attending this tertiary healthcare facility in North-Central Nigeria is high, reflecting good awareness and positive attitudes. However, completion of the full three-dose schedule remains low, with nearly half receiving only a single dose. Structural barriers, including limited access, financial constraints, inadequate follow-up, and insufficient health education, drive this gap. High willingness to complete vaccination and support for public awareness initiatives highlight opportunities for system-level interventions. Strengthening service delivery, integrating subsidized adult vaccination, and implementing reminder and follow-up mechanisms are essential to improving completion and advancing Hepatitis B prevention efforts. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1